Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 5/20 | 0.43 |
| ▸ | NFE2L2 | Q16236 | 5/20 | 0.43 |
| ▸ | ITGB3 | P05106 | 4/20 | 0.37 |
| ▸ | ITGAV | P06756 | 4/20 | 0.37 |
| ▸ | ITGB5 | P18084 | 3/20 | 0.37 |
| ▸ | ITGB6 | P18564 | 3/20 | 0.37 |
| ▸ | ITGB8 | P26012 | 3/20 | 0.37 |
| ▸ | CASP1 | P29466 | 7/20 | 0.36 |
| ▸ | FPR1 | P21462 | 2/20 | 0.34 |
| ▸ | SDCBP | O00560 | 1/20 | 0.33 |
| ▸ | SDC2 | P34741 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4427926 | 0.93 | KEAP1 (0.42) | KEAP1NFE2L2ITGB3ITGAVITGB5 | |
| SCHEMBL4430613 | 0.90 | CTSA (0.40) | KEAP1NFE2L2CASP1FPR1 | |
| SCHEMBL4426794 | 0.90 | CASP1 (0.39) | CASP1FPR1 | |
| SCHEMBL4436767 | 0.85 | CASP1 (0.39) | CASP1FPR1 | |
| SCHEMBL4425710 | 0.82 | ALDH1A1 (0.37) | KEAP1NFE2L2FPR1 | |
| SCHEMBL4436965 | 0.82 | FPR1 (0.43) | CASP1FPR1 | |
| SCHEMBL4435399 | 0.82 | CTSA (0.40) | KEAP1NFE2L2FPR1 | |
| SCHEMBL8506622 | 0.82 | CTSA (0.40) | KEAP1NFE2L2FPR1 | |
| SCHEMBL4435400 | 0.82 | CTSA (0.40) | KEAP1NFE2L2FPR1 | |
| SCHEMBL4427187 | 0.82 | MMP2 (0.38) | CASP1FPR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1213288-B1 | Propanoic acid derivatives that inhibit the binding of integrins to their receptors | ENCYSIVE PHARMACEUTICALS INC (US) | 2009-01-14 | — | — | EP | disclosed |
| EP-1213288-A1 | Propanoic acid derivatives that inhibit the binding of integrins to their receptors | TEXAS BIOTECHNOLOGY CORPORATION (US) | 2002-06-12 | — | — | EP | disclosed |